Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Fortrea Cuts FY24 Revenue Outlook From $3.14B-$3.205B To $2.785B-$2.855B, Est $3.08B

Author: Benzinga Newsdesk | May 13, 2024 06:40am

Planned divestiture of assets relating to the Endpoint Clinical and Patient Access businesses on track, the company said.

Posted In: FTRE